These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29179602)

  • 1. Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections.
    Robert MA; Nassoury N; Chahal PS; Venne MH; Racine T; Qiu X; Kobinger G; Kamen A; Gilbert R; Gaillet B
    Hum Gene Ther; 2018 Apr; 29(4):452-466. PubMed ID: 29179602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
    J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection.
    Limberis MP; Tretiakova A; Nambiar K; Wong G; Racine T; Crosariol M; Xiangguo Q; Kobinger G; Wilson JM
    J Infect Dis; 2016 Dec; 214(12):1975-1979. PubMed ID: 27683818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus.
    Qiu X; Audet J; Lv M; He S; Wong G; Wei H; Luo L; Fernando L; Kroeker A; Fausther Bovendo H; Bello A; Li F; Ye P; Jacobs M; Ippolito G; Saphire EO; Bi S; Shen B; Gao GF; Zeitlin L; Feng J; Zhang B; Kobinger GP
    Sci Transl Med; 2016 Mar; 8(329):329ra33. PubMed ID: 26962157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.
    van Lieshout LP; Soule G; Sorensen D; Frost KL; He S; Tierney K; Safronetz D; Booth SA; Kobinger GP; Qiu X; Wootton SK
    J Infect Dis; 2018 Mar; 217(6):916-925. PubMed ID: 29365142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco against Ebola virus disease.
    Budzianowski J
    Przegl Lek; 2015; 72(10):567-71. PubMed ID: 26946569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
    Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
    J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of protective antibodies reveal sites of vulnerability on Ebola virus.
    Murin CD; Fusco ML; Bornholdt ZA; Qiu X; Olinger GG; Zeitlin L; Kobinger GP; Ward AB; Saphire EO
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17182-7. PubMed ID: 25404321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
    ; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D
    N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
    Urabe M; Ding C; Kotin RM
    Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
    Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
    Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.
    Qiu X; Wong G; Audet J; Bello A; Fernando L; Alimonti JB; Fausther-Bovendo H; Wei H; Aviles J; Hiatt E; Johnson A; Morton J; Swope K; Bohorov O; Bohorova N; Goodman C; Kim D; Pauly MH; Velasco J; Pettitt J; Olinger GG; Whaley K; Xu B; Strong JE; Zeitlin L; Kobinger GP
    Nature; 2014 Oct; 514(7520):47-53. PubMed ID: 25171469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.
    Zuber C; Mitteregger G; Schuhmann N; Rey C; Knackmuss S; Rupprecht W; Reusch U; Pace C; Little M; Kretzschmar HA; Hallek M; Büning H; Weiss S
    J Gen Virol; 2008 Aug; 89(Pt 8):2055-2061. PubMed ID: 18632978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.
    Arruda VR; Fields PA; Milner R; Wainwright L; De Miguel MP; Donovan PJ; Herzog RW; Nichols TC; Biegel JA; Razavi M; Dake M; Huff D; Flake AW; Couto L; Kay MA; High KA
    Mol Ther; 2001 Dec; 4(6):586-92. PubMed ID: 11735343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
    Brockstedt DG; Podsakoff GM; Fong L; Kurtzman G; Mueller-Ruchholtz W; Engleman EG
    Clin Immunol; 1999 Jul; 92(1):67-75. PubMed ID: 10413654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.